Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective Study.

Salzmann, Martin; Wald, Alexander; Stege, Henner; Loquai, Carmen; Zimmer, Lisa; Hayani, Kinan M; Heinzerling, Lucie; Gutzmer, Ralf; Enk, Alexander H; Hassel, Jessica C

Salzmann, Martin; Wald, Alexander; Stege, Henner; Loquai, Carmen; Zimmer, Lisa; Hayani, Kinan M; Heinzerling, Lucie; Gutzmer, Ralf; Enk, Alexander H; Hassel, Jessica C.

Afiliação

Salzmann M; Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, 69120 Heidelberg, Germany.
Wald A; Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, 69120 Heidelberg, Germany.
Stege H; Department of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.
Loquai C; Department of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.
Zimmer L; Department of Dermatology, Gesundheit-Nord Hospital Bremen, 28325 Bremen, Germany.
Hayani KM; Department of Dermatology, University Hospital Essen, 45147 Essen, Germany.
Heinzerling L; Department of Dermatology, University Hospital Munich (LMU), 80336 Munich, Germany.
Gutzmer R; Department of Dermatology, University Hospital Munich (LMU), 80336 Munich, Germany.
Enk AH; Department of Dermatology, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Hassel JC; Skin Cancer Center, Department of Dermatology, Hannover Medical School, 30625 Hannover, Germany.